Winter flu lifts Adcock’s OTC drugs
Pharmaceutical manufacturer says increased demand for its winter products boosted turnover
22 August 2024 - 08:52
Pharmaceutical manufacturer Adcock Ingram’s total turnover for the year to end-June increased 6% to R9.6bn, lifted by increased demand for the group’s winter products, driven by a rise in cold and flu cases and other respiratory illnesses.
The company said on Thursday that it had increased its share and maintained its position as the leading pharmaceutical player in the SA private sector in the period under review...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.